Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatricial pemphigoid

Stefano Barabino, Maurizio Rolando, Giorgio Bentivoglio, Cristina Mingari, Sabrina Zanardi, Rosa Bellomo, Giovanni Calabria

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Purpose: To evaluate the role and the effectiveness over time of amniotic membrane transplantation (AMT) as a first-step procedure to treat conjunctival reconstruction in late-stage ocular-cicatricial pemphigoid (OCP). Design: Prospective interventional noncomparative case series. Participants: Nine eyes (9 patients) with advanced OCP. Methods: Preoperatively, the ocular surface conditions were evaluated by immunohistochemistry of conjunctival biopsy and impression cytology specimens. The amniotic membrane was obtained during cesarean section from women who were 39 weeks pregnant and seronegative for human immunodeficiency virus, hepatitis B and C, and syphilis; it was processed, histologically tested, and stored at -80° C. After scar tissue was removed, the preserved amniotic membrane was placed over the cornea, the bulbar, and tarsal conjunctiva, and was secured with 8-0 Vicryl sutures to the conjunctival edges and the deep fornices with double-armed 6-0 silk sutures. In 2 cases a double layer of amniotic membrane was transplanted. All patients received immunosuppressive systemic therapy and preservative-free tear substitutes and steroids topically for at least 6 months. During follow-up (average, 48 weeks; range, 28-96 weeks), a new standardized method was used to evaluate the fornix depth, and impression cytology testing was performed and conjunctival inflammation recorded and used as parameters for monitoring disease activity. Main Outcome Measures: Symblepharon, increased inferior fornix depth, presence of conjunctival goblet cells, and the degree of conjunctival inflammation. Results: The conjunctival surface was free from symblepharon in all subjects for the first 16 weeks. At the week 28 examination, a small area of symblepharon was present in four eyes (44.4%). The depth of the fornix was significantly (P <0.0001, analysis of variance) improved at weeks 4, 16, and 28. The normal conjunctival epithelium with goblet cells was restored in 6 of 9 eyes (66.7%) at the week 4 examination and in 4 eyes (44.4%) at the week 28 examination. Conjunctival inflammation was clinically but not statistically reduced. The visual acuity improved in 5 subjects. Conclusions: AMT can be a first-step procedure for ocular surface reconstruction in OCP, but its effectiveness deteriorates slightly over time.

Original languageEnglish
Pages (from-to)474-480
Number of pages7
JournalOphthalmology
Volume110
Issue number3
DOIs
Publication statusPublished - Mar 1 2003

Fingerprint

Benign Mucous Membrane Pemphigoid
Amnion
Transplantation
Goblet Cells
Inflammation
Sutures
Cell Biology
Polyglactin 910
Silk
Conjunctiva
Syphilis
Immunosuppressive Agents
Hepatitis C
Hepatitis B
Tears
Cesarean Section
Cornea
Visual Acuity
Cicatrix
Analysis of Variance

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatricial pemphigoid. / Barabino, Stefano; Rolando, Maurizio; Bentivoglio, Giorgio; Mingari, Cristina; Zanardi, Sabrina; Bellomo, Rosa; Calabria, Giovanni.

In: Ophthalmology, Vol. 110, No. 3, 01.03.2003, p. 474-480.

Research output: Contribution to journalArticle

Barabino, S, Rolando, M, Bentivoglio, G, Mingari, C, Zanardi, S, Bellomo, R & Calabria, G 2003, 'Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatricial pemphigoid', Ophthalmology, vol. 110, no. 3, pp. 474-480. https://doi.org/10.1016/S0161-6420(02)01892-4
Barabino, Stefano ; Rolando, Maurizio ; Bentivoglio, Giorgio ; Mingari, Cristina ; Zanardi, Sabrina ; Bellomo, Rosa ; Calabria, Giovanni. / Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatricial pemphigoid. In: Ophthalmology. 2003 ; Vol. 110, No. 3. pp. 474-480.
@article{4c21d8b3628348018951571c5fb8e278,
title = "Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatricial pemphigoid",
abstract = "Purpose: To evaluate the role and the effectiveness over time of amniotic membrane transplantation (AMT) as a first-step procedure to treat conjunctival reconstruction in late-stage ocular-cicatricial pemphigoid (OCP). Design: Prospective interventional noncomparative case series. Participants: Nine eyes (9 patients) with advanced OCP. Methods: Preoperatively, the ocular surface conditions were evaluated by immunohistochemistry of conjunctival biopsy and impression cytology specimens. The amniotic membrane was obtained during cesarean section from women who were 39 weeks pregnant and seronegative for human immunodeficiency virus, hepatitis B and C, and syphilis; it was processed, histologically tested, and stored at -80° C. After scar tissue was removed, the preserved amniotic membrane was placed over the cornea, the bulbar, and tarsal conjunctiva, and was secured with 8-0 Vicryl sutures to the conjunctival edges and the deep fornices with double-armed 6-0 silk sutures. In 2 cases a double layer of amniotic membrane was transplanted. All patients received immunosuppressive systemic therapy and preservative-free tear substitutes and steroids topically for at least 6 months. During follow-up (average, 48 weeks; range, 28-96 weeks), a new standardized method was used to evaluate the fornix depth, and impression cytology testing was performed and conjunctival inflammation recorded and used as parameters for monitoring disease activity. Main Outcome Measures: Symblepharon, increased inferior fornix depth, presence of conjunctival goblet cells, and the degree of conjunctival inflammation. Results: The conjunctival surface was free from symblepharon in all subjects for the first 16 weeks. At the week 28 examination, a small area of symblepharon was present in four eyes (44.4{\%}). The depth of the fornix was significantly (P <0.0001, analysis of variance) improved at weeks 4, 16, and 28. The normal conjunctival epithelium with goblet cells was restored in 6 of 9 eyes (66.7{\%}) at the week 4 examination and in 4 eyes (44.4{\%}) at the week 28 examination. Conjunctival inflammation was clinically but not statistically reduced. The visual acuity improved in 5 subjects. Conclusions: AMT can be a first-step procedure for ocular surface reconstruction in OCP, but its effectiveness deteriorates slightly over time.",
author = "Stefano Barabino and Maurizio Rolando and Giorgio Bentivoglio and Cristina Mingari and Sabrina Zanardi and Rosa Bellomo and Giovanni Calabria",
year = "2003",
month = "3",
day = "1",
doi = "10.1016/S0161-6420(02)01892-4",
language = "English",
volume = "110",
pages = "474--480",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatricial pemphigoid

AU - Barabino, Stefano

AU - Rolando, Maurizio

AU - Bentivoglio, Giorgio

AU - Mingari, Cristina

AU - Zanardi, Sabrina

AU - Bellomo, Rosa

AU - Calabria, Giovanni

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Purpose: To evaluate the role and the effectiveness over time of amniotic membrane transplantation (AMT) as a first-step procedure to treat conjunctival reconstruction in late-stage ocular-cicatricial pemphigoid (OCP). Design: Prospective interventional noncomparative case series. Participants: Nine eyes (9 patients) with advanced OCP. Methods: Preoperatively, the ocular surface conditions were evaluated by immunohistochemistry of conjunctival biopsy and impression cytology specimens. The amniotic membrane was obtained during cesarean section from women who were 39 weeks pregnant and seronegative for human immunodeficiency virus, hepatitis B and C, and syphilis; it was processed, histologically tested, and stored at -80° C. After scar tissue was removed, the preserved amniotic membrane was placed over the cornea, the bulbar, and tarsal conjunctiva, and was secured with 8-0 Vicryl sutures to the conjunctival edges and the deep fornices with double-armed 6-0 silk sutures. In 2 cases a double layer of amniotic membrane was transplanted. All patients received immunosuppressive systemic therapy and preservative-free tear substitutes and steroids topically for at least 6 months. During follow-up (average, 48 weeks; range, 28-96 weeks), a new standardized method was used to evaluate the fornix depth, and impression cytology testing was performed and conjunctival inflammation recorded and used as parameters for monitoring disease activity. Main Outcome Measures: Symblepharon, increased inferior fornix depth, presence of conjunctival goblet cells, and the degree of conjunctival inflammation. Results: The conjunctival surface was free from symblepharon in all subjects for the first 16 weeks. At the week 28 examination, a small area of symblepharon was present in four eyes (44.4%). The depth of the fornix was significantly (P <0.0001, analysis of variance) improved at weeks 4, 16, and 28. The normal conjunctival epithelium with goblet cells was restored in 6 of 9 eyes (66.7%) at the week 4 examination and in 4 eyes (44.4%) at the week 28 examination. Conjunctival inflammation was clinically but not statistically reduced. The visual acuity improved in 5 subjects. Conclusions: AMT can be a first-step procedure for ocular surface reconstruction in OCP, but its effectiveness deteriorates slightly over time.

AB - Purpose: To evaluate the role and the effectiveness over time of amniotic membrane transplantation (AMT) as a first-step procedure to treat conjunctival reconstruction in late-stage ocular-cicatricial pemphigoid (OCP). Design: Prospective interventional noncomparative case series. Participants: Nine eyes (9 patients) with advanced OCP. Methods: Preoperatively, the ocular surface conditions were evaluated by immunohistochemistry of conjunctival biopsy and impression cytology specimens. The amniotic membrane was obtained during cesarean section from women who were 39 weeks pregnant and seronegative for human immunodeficiency virus, hepatitis B and C, and syphilis; it was processed, histologically tested, and stored at -80° C. After scar tissue was removed, the preserved amniotic membrane was placed over the cornea, the bulbar, and tarsal conjunctiva, and was secured with 8-0 Vicryl sutures to the conjunctival edges and the deep fornices with double-armed 6-0 silk sutures. In 2 cases a double layer of amniotic membrane was transplanted. All patients received immunosuppressive systemic therapy and preservative-free tear substitutes and steroids topically for at least 6 months. During follow-up (average, 48 weeks; range, 28-96 weeks), a new standardized method was used to evaluate the fornix depth, and impression cytology testing was performed and conjunctival inflammation recorded and used as parameters for monitoring disease activity. Main Outcome Measures: Symblepharon, increased inferior fornix depth, presence of conjunctival goblet cells, and the degree of conjunctival inflammation. Results: The conjunctival surface was free from symblepharon in all subjects for the first 16 weeks. At the week 28 examination, a small area of symblepharon was present in four eyes (44.4%). The depth of the fornix was significantly (P <0.0001, analysis of variance) improved at weeks 4, 16, and 28. The normal conjunctival epithelium with goblet cells was restored in 6 of 9 eyes (66.7%) at the week 4 examination and in 4 eyes (44.4%) at the week 28 examination. Conjunctival inflammation was clinically but not statistically reduced. The visual acuity improved in 5 subjects. Conclusions: AMT can be a first-step procedure for ocular surface reconstruction in OCP, but its effectiveness deteriorates slightly over time.

UR - http://www.scopus.com/inward/record.url?scp=0037372185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037372185&partnerID=8YFLogxK

U2 - 10.1016/S0161-6420(02)01892-4

DO - 10.1016/S0161-6420(02)01892-4

M3 - Article

C2 - 12623807

AN - SCOPUS:0037372185

VL - 110

SP - 474

EP - 480

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 3

ER -